Niagen Bioscience Inc
NASDAQ: NAGE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Robert N. Fried
- Employees
- 104
- Headquarters
- Los Angeles, United States
- IPO year
- 2015
- Market cap
- $274.8M
- Website
- https://www.niagenbioscience.com
Loading NAGE…
Loading profile data…Frequently asked questions about NAGE
What does Niagen Bioscience Inc (NAGE) do?
Niagen Bioscience Inc operates as a biotechnology enterprise with a core focus on promoting healthy aging. This company is also renowned for its pioneering research into nicotinamide adenine dinucleotide.
Where does NAGE trade?
Niagen Bioscience Inc (NAGE) trades on the NASDAQ Capital Market.
What sector is NAGE in?
Niagen Bioscience Inc (NAGE) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Niagen Bioscience Inc?
Robert N. Fried is the chief executive officer of Niagen Bioscience Inc (NAGE).
Where is Niagen Bioscience Inc headquartered?
Niagen Bioscience Inc is headquartered in United States.
Does NAGE pay a dividend?
Niagen Bioscience Inc (NAGE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NAGE go public?
Niagen Bioscience Inc (NAGE) completed its initial public offering in 2015.